Your browser doesn't support javascript.
loading
Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing.
Sims, Matthew D; Podolsky, Robert H; Childers, Karen L; Higgins, Barbara; Trueman, Jillian; Homayouni, Ramin; Voss, Daniel R; Berkiw-Scenna, Natalie; Keil, Hans; Kennedy, Richard H; Maine, Gabriel N.
Affiliation
  • Sims MD; Section of Infectious Diseases and International Medicine, Department of Internal Medicine, Beaumont Royal Oak, Royal Oak, MI, USA; Department of Internal Medicine, Oakland University William Beaumont School of Medicine, Rochester, MI, USA; Department of Foundational Medical Studies, Oakland Univers
  • Podolsky RH; Biostatistics, Beaumont Research Institute, Royal Oak, MI, USA.
  • Childers KL; Biostatistics, Beaumont Research Institute, Royal Oak, MI, USA.
  • Higgins B; Research Education and Process Improvement, Beaumont Research Institute, Royal Oak, MI, USA.
  • Trueman J; Department of Pathology and Laboratory Medicine, Beaumont Royal Oak, Royal Oak, MI, USA.
  • Homayouni R; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA.
  • Voss DR; Research Computing, Beaumont Research Institute, Royal Oak, MI, USA.
  • Berkiw-Scenna N; Project Management Office, Beaumont Health, Southfield, MI, USA.
  • Keil H; Beaumont Health, Information Technology, Southfield, MI, USA.
  • Kennedy RH; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI, USA; Beaumont Research Institute, Royal Oak, MI, USA.
  • Maine GN; Department of Pathology and Laboratory Medicine, Beaumont Royal Oak, Royal Oak, MI, USA; Department of Pathology, Oakland University William Beaumont School of Medicine, Rochester, MI, USA. Electronic address: gabriel.maine@beaumont.edu.
J Immunol Methods ; 513: 113420, 2023 02.
Article in En | MEDLINE | ID: mdl-36596443
BACKGROUND: Serologic analysis is an important tool towards assessing the humoral response to COVID-19 infection and vaccination. Numerous serologic tests and platforms are currently available to support this line of testing. Two broad antibody testing categories are point-of-care lateral flow immunoassays and semi-quantitative immunoassays performed in clinical laboratories, which typically require blood collected from a finger-stick and a standard venipuncture blood draw, respectively. This study evaluated the use of dried blood spot (DBS) collections as a sample source for COVID-19 antibody testing using an automated clinical laboratory test system. METHODS: Two hundred and ninety-four participants in the BLAST COVID-19 seroprevalence study (NCT04349202) were recruited at the time of a scheduled blood draw to have an additional sample taken via finger stick as a DBS collection. Using the EUROIMMUN assay to assess SARS-CoV-2 anti-spike IgG status, DBS specimens were tested on 7, 14, 21, and 28 days post- collection and compared to the reference serum sample obtained from a blood draw for the BLAST COVID-19 study. RESULTS: SARS-CoV-2 anti-spike IgG status from DBS collections demonstrated high concordance with serum across all time points (7-28 days). However, the semi-quantitative value from DBS collections was lower on average than that from serum, resulting in increased uncertainty around the equivocal-to-positive analytical decision point. CONCLUSIONS: DBS collections can be substituted for venipuncture when assaying for COVID-19 IgG antibody, with samples being stable for at least 28 days at room temperature. Finger-stick sampling can therefore be advantageous for testing large populations for SARS-CoV-2 antibodies without the need for phlebotomists or immediate processing of samples. We have high confidence in serostaus determination from DBS collections, although the reduced semi-quantitative value may cause some low-level positives to fall into the equivocal or even negative range.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limits: Humans Language: En Journal: J Immunol Methods Year: 2023 Document type: Article Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limits: Humans Language: En Journal: J Immunol Methods Year: 2023 Document type: Article Country of publication: Países Bajos